Playback speed
10 seconds
EADV 2023 Insights: Understanding the Differences Between MOA and Target of Deucravacitinib Versus Other Approved JAKis
By
EADV 2023 Insights
FEATURING
Leon Kircik
By
EADV 2023 Insights
FEATURING
Leon Kircik
0 views
October 9, 2023
Comments 1
Login to view comments.
Click here to Login